BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 19582217)

  • 1. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
    Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
    Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol: A Focus on Several Neurodegenerative Diseases.
    Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
    Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein transmission in neurodegenerative disease.
    Peng C; Trojanowski JQ; Lee VM
    Nat Rev Neurol; 2020 Apr; 16(4):199-212. PubMed ID: 32203399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
    Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
    Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
    Fang M; Liu Y; Huang C; Fan S
    Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitophagy Regulates Neurodegenerative Diseases.
    Cen X; Zhang M; Zhou M; Ye L; Xia H
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
    Rivera S; García-González L; Khrestchatisky M; Baranger K
    Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.
    Shrivastava AN; Aperia A; Melki R; Triller A
    Neuron; 2017 Jul; 95(1):33-50. PubMed ID: 28683268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases.
    Borza LR
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):19-27. PubMed ID: 24741770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic neurodegenerative diseases: the human illness and transgenic models.
    Price DL; Sisodia SS; Borchelt DR
    Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
    Di Domenico F; Tramutola A; Butterfield DA
    Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.